334 filings
Page 6 of 17
8-K
zgf 7vkf6w
27 Apr 22
T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel
8:30am
8-K
5hoq1ju6ol
12 Apr 22
Regulation FD Disclosure
4:01pm
8-K/A
lwc6o
1 Apr 22
Entry into a Material Definitive Agreement
4:01pm
8-K
rfbzrk0 xy1tyj05xn
31 Mar 22
Entry into a Material Definitive Agreement
7:20pm
8-K
if05il0cm3chs
17 Feb 22
T2 Biosystems Announces Fourth Quarter & Full Year 2021 Financial Results
5:30pm
8-K
7kp8jj4vk6
11 Jan 22
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2021 Results
9:15am
8-K
jkpi5lj8q76 j328
9 Nov 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:07pm
8-K
x1dshe04i5rxq3x 54cu
5 Nov 21
T2 Biosystems Announces Third Quarter 2021 Financial Results
4:01pm
8-K
9wc 5pxaecq1p
19 Oct 21
Departure of Directors or Certain Officers
4:31pm
8-K
c7c3o1 7dto4e
4 Oct 21
Entry into a Material Definitive Agreement
4:29pm
8-K
hla1 11d5orxx4j
8 Sep 21
Entry into a Material Definitive Agreement
4:06pm
8-K
l08uhu7c8
10 Aug 21
T2 Biosystems Announces Second Quarter 2021 Financial Results
4:01pm
8-K
d6m7im91mpww8lfv 0qu
23 Jul 21
Departure of Directors or Certain Officers
4:00pm
DEFA14A
gtmmgmnu5aj
13 Jul 21
Additional proxy soliciting materials
4:00pm
8-K
c1ejchuoos ijobi
28 Jun 21
Departure of Directors or Certain Officers
4:00pm
DEFA14A
1zw mguvlusw9gajls1
11 Jun 21
Additional proxy soliciting materials
9:18am
SD
9e0d cb4exa08vvygy
1 Jun 21
Conflict minerals disclosure
4:00pm